Magri argues that managed care organizations are having trouble treating their diabetic patients and will welcome a new option.
FORBES: Merck Starts Diabetes Race
2.
Readying Merck's big drug launch, Magri emphasizes that the diabetes market is one that will develop over years, not months.
FORBES: Magazine Article
3.
"I know our customers are going to embrace Januvia from the moment we put it on the marketplace, " says Patrick Magri , the Merck vice president who will lead the marketing effort for the drug.